Literature DB >> 22809487

Familial Turner syndrome with an X;Y translocation mosaicism: implications for genetic counseling.

Marie-France Portnoï1, Sandra Chantot-Bastaraud, Sophie Christin-Maitre, Bruno Carbonne, Marie-Paule Beaujard, Boris Keren, Jonathan Lévy, Marc Dommergues, Sylvie Cabrol, Capucine Hyon, Jean-Pierre Siffroi.   

Abstract

Spontaneous fertility is rare among patients with Turner syndrome and is most likely in women with mosaicism for a normal 46,XX cell line. We report an unusual case of familial Turner syndrome with mosaicism for a novel X;Y translocation involving Xp and Yp. The chromosomal analysis was carried out through cytogenetics and molecular karyotyping using a SNP array platform. The mother, a Turner syndrome woman, diagnosed in midchildhood because of short stature, was found to have a 45,X/46,X,der(X)t(X;Y)(p11.4;p11.2) karyotype, with a predominant 45,X cell line. Her parents decided against prophylactic gonadectomy, generally recommended at an early age when Y chromosome has been identified, because at age 13, she had spontaneous puberty and menarche. She reached a final height of 154 cm after treatment with growth hormone. At age 24, she became spontaneously pregnant. She had a mild aortic coarctation and close follow-up cardiac evaluation, including cardiac magnetic resonance imaging, had been performed during her pregnancy, which progressed uneventfully, except for intra-uterine growth retardation. Prenatal diagnosis revealed a female karyotype, with transmission of the maternal translocation with an unexpected different mosaic:47,X,der(X)t(X;Y)x2/46,X,der(X)t(X;Y) karyotype. This complex and unusual karyotype, including a mosaic partial trisomy X and a non-mosaic Xpter-Xp11.4 monosomy, results in transmission of Turner syndrome from mother to daughter. At birth, the girl had normal physical examination except for growth retardation. This family illustrates the complexity and difficulties, in term of patient counseling and management in Turner syndrome, in determining ovarian status, fertility planning, risks associated with pregnancies, particularly when mosaicism for Y material chromosome is identified.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22809487     DOI: 10.1016/j.ejmg.2012.07.001

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  6 in total

1.  Diagnosis of turner syndrome in two mothers following their daughters' diagnosis.

Authors:  M Pilar Bahíllo-Curieses; Sofía Galbis-Soto; M Concepción Mombiedro-Arizmendi
Journal:  Endocrine       Date:  2016-02-09       Impact factor: 3.633

2.  Turner Syndrome with Y Chromosome: Spontaneous Thelarche, Menarche, and Risk of Malignancy.

Authors:  Elizabeth Dabrowski; Emilie K Johnson; Vrunda Patel; YeoChing Hsu; Shanlee Davis; Allison L Goetsch; Reema Habiby; Wendy J Brickman; Courtney Finlayson
Journal:  J Pediatr Adolesc Gynecol       Date:  2019-08-26       Impact factor: 1.814

3.  45,X mosaicism in northeast China: a clinical report and review of the literature.

Authors:  Xiang-Yin Liu; Hong-Guo Zhang; Shuang Chen; Rui-Xue Wang; Zhi-Hong Zhang; Rui-Zhi Liu
Journal:  J Assist Reprod Genet       Date:  2013-01-09       Impact factor: 3.412

4.  Rare congenital chromosomal aberration dic(X;Y)(p22.33;p11.32) in a patient with primary myelofibrosis.

Authors:  Lenka Pavlistova; Silvia Izakova; Zuzana Zemanova; Lucie Bartuskova; Martina Langova; Pavlina Malikova; Kyra Michalova
Journal:  Mol Cytogenet       Date:  2016-08-31       Impact factor: 2.009

5.  Rare copy number variants in the genome of Chinese female children and adolescents with Turner syndrome.

Authors:  Li Li; Qingfeng Li; Qiong Wang; Li Liu; Ru Li; Huishu Liu; Yaojuan He; Gendie E Lash
Journal:  Biosci Rep       Date:  2019-01-11       Impact factor: 3.840

6.  Effects of recombinant human growth hormone therapy on carbohydrate, lipid and protein metabolisms of children with Turner syndrome.

Authors:  Weibin Qi; Shuxian Li; Qiong Shen; Xiuxia Guo; Huijuan Rong
Journal:  Pak J Med Sci       Date:  2014-07       Impact factor: 1.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.